Atopic dermatitis phenotype with early onset and high serum IL-13 is linked to the new development of bronchial hyperresponsiveness in school children

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 71, Issue 5, 2016, Pages 692-700

  Lee, E ^a   Lee, S H ^a   Kwon, J W ^b   Kim, Y H ^a   Cho, H J ^a   Yang, S I ^c   Jung, Y H ^d   Kim, H Y ^e   Seo, J H ^f   Kim, B J ^g   Kim, H B ^h   Lee, S Y ^c   Kwon, H J ⁱ   Hong, S J ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c Hallym University   (South Korea)

^d CHA University   (South Korea)

^e Pusan National University Yangsan Hospital   (South Korea)

^f Korea Cancer Center Hospital   (South Korea)

^g UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^h Inje University College of Medicine   (South Korea)

ⁱ Dankook University College of Medicine   (South Korea)

Author keywords

allergic March; atopic dermatitis; bronchial; hyperresponsiveness; IL 13; phenotype

Indexed keywords

INTERLEUKIN 13; THYMIC STROMAL LYMPHOPOIETIN; BIOLOGICAL MARKER; CYTOKINE; IMMUNOGLOBULIN E;

ARTICLE; ATOPIC DERMATITIS; ATOPY; BRONCHIAL HYPERRESPONSIVENESS; BRONCHUS DISEASE; CHILD; ENVIRONMENTAL FACTOR; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; EOSINOPHILIA; FEMALE; FOLLOW UP; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRICK TEST; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY TRACT ALLERGY; SKIN TEST; AGE; BLOOD; BRONCHUS HYPERREACTIVITY; CLUSTER ANALYSIS; COMORBIDITY; COMPLICATION; IMMUNOLOGY; LUNG FUNCTION TEST; PROGNOSIS; QUESTIONNAIRE; RISK FACTOR;

AGE FACTORS; BIOMARKERS; BRONCHIAL HYPERREACTIVITY; CHILD; CLUSTER ANALYSIS; COMORBIDITY; CYTOKINES; DERMATITIS, ATOPIC; FEMALE; HUMANS; IMMUNOGLOBULIN E; INTERLEUKIN-13; MALE; PHENOTYPE; PROGNOSIS; RESPIRATORY FUNCTION TESTS; RISK FACTORS; SURVEYS AND QUESTIONNAIRES;

EID: 84971654761     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12844     Document Type: Article

References (51)

1. Leung DY, Bieber T,. Atopic dermatitis. Lancet 2003; 361: 151-160.
2. Asher MI, Montefort S, Bjorksten B, Lai CK, Strachan DP, Weiland SK, et al., Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006; 368: 733-743.
3. Kim WK, Kwon JW, Seo JH, Kim HY, Yu J, Kim BJ, et al., Interaction between IL13 genotype and environmental factors in the risk for allergic rhinitis in Korean children. J Allergy Clin Immunol 2012; 130: 421-426.
4. Carroll CL, Balkrishnan R, Feldman SR, Fleischer AB Jr, Manuel JC,. The burden of atopic dermatitis: impact on the patient, family, and society. Pediatr Dermatol 2005; 22: 192-199.
5. Chang HY, Seo JH, Kim HY, Kwon JW, Kim BJ, Kim HB, et al., Allergic diseases in preschoolers are associated with psychological and behavioural problems. Allergy Asthma Immunol Res 2013; 5: 315-321.
6. von Kobyletzki LB, Bornehag CG, Hasselgren M, Larsson M, Lindstrom CB, Svensson A,. Eczema in early childhood is strongly associated with the development of asthma and rhinitis in a prospective cohort. BMC Dermatol 2012; 12: 11.
7. Arshad SH, Kurukulaaratchy RJ, Fenn M, Matthews S,. Early life risk factors for current wheeze, asthma, and bronchial hyperresponsiveness at 10 years of age. Chest 2005; 127: 502-508.
8. Lowe AJ, Carlin JB, Bennett CM, Hosking CS, Abramson MJ, Hill DJ, et al., Do boys do the atopic march while girls dawdle? J Allergy Clin Immunol 2008; 121: 1190-1195.
9. Carlsten C, Dimich-Ward H, Ferguson A, Watson W, Rousseau R, Dybuncio A, et al., Atopic dermatitis in a high-risk cohort: natural history, associated allergic outcomes, and risk factors. Ann Allergy Asthma Immunol 2013; 110: 24-28.
10. van der Hulst AE, Klip H, Brand PL,. Risk of developing asthma in young children with atopic eczema: a systematic review. J Allergy Clin Immunol 2007; 120: 565-569.
11. Illi S, von Mutius E, Lau S, Nickel R, Gruber C, Niggemann B, et al., The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J Allergy Clin Immunol 2004; 113: 925-931.
12. Ricci G, Dondi A, Neri I, Ricci L, Patrizi A, Pession A,. Atopic dermatitis phenotypes in childhood. Ital J Pediatr 2014; 40: 46.
13. Loo EX, Shek LP, Goh A, Teoh OH, Chan YH, Soh SE, et al., Atopic dermatitis in early life: evidence for at least three phenotypes? Results from the GUSTO study. Int Arch Allergy Immunol 2015; 166: 273-279.
14. Zhu Z, Oh MH, Yu J, Liu YJ, Zheng T,. The role of TSLP in IL-13-induced atopic march. Sci Rep 2011; 1: 23.
15. Leyva-Castillo JM, Hener P, Jiang H, Li M,. TSLP produced by keratinocytes promotes allergen sensitization through skin and thereby triggers atopic march in mice. J Invest Dermatol 2013; 133: 154-163.
16. Kim HJ, Kim YJ, Lee SH, Yu J, Jeong SK, Hong SJ,. Effects of Lactobacillus rhamnosus on allergic march model by suppressing Th2, Th17, and TSLP responses via CD4(+)CD25(+)Foxp3(+) Tregs. Clin Immunol 2014; 153: 178-186.
17. Jiang H, Hener P, Li J, Li M,. Skin thymic stromal lymphopoietin promotes airway sensitization to inhalant house dust mites leading to allergic asthma in mice. Allergy 2012; 67: 1078-1082.
18. Ha M, Kwon HJ, Lim MH, Jee YK, Hong YC, Leem JH, et al., Low blood levels of lead and mercury and symptoms of attention deficit hyperactivity in children: a report of the children's health and environment research (CHEER). Neurotoxicology 2009; 30: 31-36.
19. Kim BJ, Seo JH, Jung YH, Kim HY, Kwon JW, Kim HB, et al., Air pollution interacts with past episodes of bronchiolitis in the development of asthma. Allergy 2013; 68: 517-523.
20. Kim BJ, Lee SY, Kwon JW, Jung YH, Lee E, Yang SI, et al., Traffic-related air pollution is associated with airway hyperresponsiveness. J Allergy Clin Immunol 2014; 133: 1763-1765.
21. Asher MI, Keil U, Anderson HR, Beasley R, Crane J, Martinez F, et al., International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J 1995; 8: 483-491.
22. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al., Standardisation of spirometry. Eur Respir J 2005; 26: 319-338.
23. Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, et al., Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 2000; 161: 309-329.
24. Hagenaars J, McCutcheon A,. Applied Latent Class Analysis. Cambridge: Cambridge University Press, 2002.
25. Siroux V, Basagana X, Boudier A, Pin I, Garcia-Aymerich J, Vesin A, et al., Identifying adult asthma phenotypes using a clustering approach. Eur Respir J 2011; 38: 310-317.
26. Howrylak JA, Fuhlbrigge AL, Strunk RC, Zeiger RS, Weiss ST, Raby BA, et al., Classification of childhood asthma phenotypes and long-term clinical responses to inhaled anti-inflammatory medications. J Allergy Clin Immunol 2014; 133: 1289-1300.
27. Moore WC, Meyers DA, Wenzel SE, Teague WG, Li H, Li X, et al., Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med 2010; 181: 315-323.
28. Zheng T, Yu J, Oh MH, Zhu Z,. The atopic march: progression from atopic dermatitis to allergic rhinitis and asthma. Allergy Asthma Immunol Res 2011; 3: 67-73.
29. Weinmayr G, Keller F, Kleiner A, du Prel JB, Garcia-Marcos L, Batlles-Garrido J, et al., Asthma phenotypes identified by latent class analysis in the ISAAC phase II Spain study. Clin Exp Allergy 2013; 43: 223-232.
30. Tan RA, Corren J,. The relationship of rhinitis and asthma, sinusitis, food allergy, and eczema. Immunol Allergy Clin North Am 2011; 31: 481-491.
31. Holguin F,. The atopic march: IgE is not the only road. Lancet Respir Med 2014; 2: 88-90.
32. Danso MO, van Drongelen V, Mulder A, van Esch J, Scott H, van Smeden J, et al., TNF-alpha and Th2 cytokines induce atopic dermatitis-like features on epidermal differentiation proteins and stratum corneum lipids in human skin equivalents. J Invest Dermatol 2014; 134: 1941-1950.
33. Masuoka M, Shiraishi H, Ohta S, Suzuki S, Arima K, Aoki S, et al., Periostin promotes chronic allergic inflammation in response to Th2 cytokines. J Clin Invest 2012; 122: 2590-2600.
34. Yu HS, Kang MJ, Kwon JW, Lee SY, Lee E, Yang SI, et al., Claudin-1 polymorphism modifies the effect of mold exposure on the development of atopic dermatitis and production of IgE. J Allergy Clin Immunol 2015; 135: 827-830.
35. Liu FT, Goodarzi H, Chen HY,. IgE, mast cells, and eosinophils in atopic dermatitis. Clin Rev Allergy Immunol 2011; 41: 298-310.
36. Leckie MJ, ten Brinke A, Khan J, Diamant Z, O'Connor BJ, Walls CM, et al., Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000; 356: 2144-2148.
37. Justice JP, Borchers MT, Crosby JR, Hines EM, Shen HH, Ochkur SI, et al., Ablation of eosinophils leads to a reduction of allergen-induced pulmonary pathology. Am J Physiol Lung Cell Mol Physiol 2003; 284: L169-L178.
38. Schmid-Grendelmeier P, Altznauer F, Fischer B, Bizer C, Straumann A, Menz G, et al., Eosinophils express functional IL-13 in eosinophilic inflammatory diseases. J Immunol 2002; 169: 1021-1027.
39. Pope SM, Brandt EB, Mishra A, Hogan SP, Zimmermann N, Matthaei KI, et al., IL-13 induces eosinophil recruitment into the lung by an IL-5- and eotaxin-dependent mechanism. J Allergy Clin Immunol 2001; 108: 594-601.
40. Hamid Q, Naseer T, Minshall EM, Song YL, Boguniewicz M, Leung DY,. In vivo expression of IL-12 and IL-13 in atopic dermatitis. J Allergy Clin Immunol 1996; 98: 225-231.
41. Takayama G, Arima K, Kanaji T, Toda S, Tanaka H, Shoji S, et al., Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. J Allergy Clin Immunol 2006; 118: 98-104.
42. Zheng T, Oh MH, Oh SY, Schroeder JT, Glick AB, Zhu Z,. Transgenic expression of interleukin-13 in the skin induces a pruritic dermatitis and skin remodeling. J Invest Dermatol 2009; 129: 742-751.
43. Kagi MK, Joller-Jemelka H, Wuthrich B,. Correlation of eosinophils, eosinophil cationic protein and soluble interleukin-2 receptor with the clinical activity of atopic dermatitis. Dermatology 1992; 185: 88-92.
44. Uehara M, Izukura R, Sawai T,. Blood eosinophilia in atopic dermatitis. Clin Exp Dermatol 1990; 15: 264-266.
45. Nowacki Z, Neuberg J, Strzalka K, Szczepanik M, Szczepanik R, Mazurek H,. Is prediction of the allergic march possible on the basis of nasal cytology? Pneumonol Alergol Pol 2010; 78: 263-270.
46. Pinart M, Benet M, Annesi-Maesano I, von Berg A, Berdel D, Carlsen KC, et al., Comorbidity of eczema, rhinitis, and asthma in IgE-sensitised and non-IgE-sensitised children in MeDALL: a population-based cohort study. Lancet Respir Med 2014; 2: 131-140.
47. Spergel JM,. Atopic march: link to upper airways. Curr Opin Allergy Clin Immunol 2005; 5: 17-21.
48. Williams H, Flohr C,. How epidemiology has challenged 3 prevailing concepts about atopic dermatitis. J Allergy Clin Immunol 2006; 118: 209-213.
49. Novak N, Bieber T, Leung DY,. Immune mechanisms leading to atopic dermatitis. J Allergy Clin Immunol 2003; 112: S128-S139.
50. Spergel JM, Paller AS,. Atopic dermatitis and the atopic march. J Allergy Clin Immunol 2003; 112: S118-S127.
51. Laske N, Bunikowski R, Niggemann B,. Extraordinarily high serum IgE levels and consequences for atopic phenotypes. Ann Allergy Asthma Immunol 2003; 91: 202-204.